Nerve News and Research

RSS

Education slows down development of dementia: Researchers

Researchers have discovered that education not only delays the early symptoms of dementia, but can also slow down the development of the disease - a finding that could result in faster diagnosis and treatment of dementia, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

31 May 2010

NewYork-Presbyterian Hospital/Columbia University Medical Center announce presentations at American Urological Association meeting

Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American Urological Association Annual Meeting in San Francisco, May 29 to June 3.

31 May 2010

Adenosine plays major role in parlaying effects of acupuncture

Scientists have taken another important step toward understanding just how sticking needles into the body can ease pain.

31 May 2010

Today's Opinions: Never-events, Medicare 'propaganda' and drug copays

According to the Labor Department, overall inflation has averaged about 2.5 percent annually, and prescription drug prices have gone up about 3.6 percent each year, over that time frame. Co-pays, though, have increased four times faster than inflation (Peter J. Pitts, 5/28).

29 May 2010

New study provides cause-and-effect link between immune system cells and mental illness

A Nobel Prize-winning University of Utah geneticist discovered that bone marrow transplants cure mutant mice who pull out their hair compulsively. The study provides the first cause-and-effect link between immune system cells and mental illness, and points toward eventual new psychiatric treatments.

28 May 2010

Uroplasty reports strong sales growth for Macroplastique in fourth-quarter 2010

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fourth fiscal quarter and full year ended March 31, 2010. The results were highlighted by continued strong U.S. sales growth for Macroplastique and a reduction in operating and net loss compared to the prior year.

28 May 2010

Leading stem cell scientists to discuss on stem cell clinical trials for ALS and heart attack patients

The first Cedars-Sinai Regenerative Medicine Scientific Symposium, dedicated to furthering our ability to bring stem cell therapies from the laboratory to the patient bedside. The conference, led by Clive Svendsen, Ph.D., and Eduardo Marb-n, M.D., Ph.D., will highlight the most recent developments in leading-edge stem cell research and treatments for brain and heart diseases.

27 May 2010

Diving "feet first" can prevent spinal cord injuries

Matt, a Dearborn, Mich. resident, is featured in an award-winning video "Shattered Dreams," commissioned by the University of Michigan's Department of Neurosurgery as part of an injury prevention effort. Public service announcements based on the video begin airing in southeastern Michigan movie theatres June 4 to spread the message of "feet first" to boaters and swimmers.

27 May 2010

Canadian Diabetes Association urges people with diabetes to quit smoking to improve overall health

Smoking while having diabetes is a deadly combination - in recognition of the World Health Organization's World No Tobacco Day taking place on May 31, 2010, the Canadian Diabetes Association is urging Canadians living with diabetes who smoke to take charge of their health by knowing their risks and to take action to quit smoking.

27 May 2010

UCI scientists create eight-layer, early-stage retina from human embryonic stem cells

UC Irvine scientists have created an eight-layer, early-stage retina from human embryonic stem cells, the first three-dimensional tissue structure to be made from stem cells.

27 May 2010

Researchers use new imaging technique to view microvessels in the brains of living mice

Researchers at Northwestern University Feinberg School of Medicine have identified in mice a previously unknown protective mechanism by which the smallest blood vessels remove blood clots and other blockages from the brain. The findings provide insights into mechanisms that may be involved in age-related cognitive decline, Alzheimer's disease and recovery from stroke.

27 May 2010

Impulse Monitoring signs agreement to provide Tufts Medical Center IONM services

Impulse Monitoring, Inc. (IMI), a leading provider of intraoperative neurophysiological monitoring (IONM) services to hospitals, today announced that it has signed an agreement with Tufts Medical Center, Boston to provide comprehensive IONM services, including real-time physician oversight.

27 May 2010

Researchers discover gene mutations in autistic, mentally impaired patients

Researchers working with Professor Gudrun Rappold, Director of the Department of Molecular Human Genetics at Heidelberg University Hospital, have discovered previously unknown mutations in autistic and mentally impaired patients in what is known as the SHANK2 gene, a gene that is partially responsible for linking nerve cells.

26 May 2010

UCSF scientists discover new stem cell in developing human brain

UCSF scientists have discovered a new stem cell in the developing human brain. The cell produces nerve cells that help form the neocortex - the site of higher cognitive function -- and likely accounts for the dramatic expansion of the region in the lineages that lead to man, the researchers say.

26 May 2010

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

Trigemina, Inc., a Mountain View based privately-held biopharmaceutical company, reports positive results from a time-based interim analysis of its Phase IIa clinical trial in Chronic Daily Headache. The trial is a collaborative effort between Trigemina and Dr. Egilius Spierings of MedVadis Research Corporation located outside of Boston. The study compares intranasal oxytocin with placebo in patients suffering from CDH.

26 May 2010

Medtronic fiscal year 2010 revenue up 8% to $15.817 billion

Medtronic, Inc. today announced financial results for its fourth quarter and fiscal year ended April 30, 2010.

25 May 2010

Biogen Idec, Abbott commence enrollment in Phase III comparative study of daclizumab to AVONEX for RRMS

Biogen Idec and Abbott today announced enrollment of the first patient in a global Phase III study evaluating the efficacy and safety of daclizumab compared to interferon beta-1a (AVONEX®) in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).

25 May 2010

Nerve News and Research

Education slows down development of dementia: Researchers

NewYork-Presbyterian Hospital/Columbia University Medical Center announce presentations at American Urological Association meeting

Adenosine plays major role in parlaying effects of acupuncture

Today's Opinions: Never-events, Medicare 'propaganda' and drug copays

New study provides cause-and-effect link between immune system cells and mental illness

Uroplasty reports strong sales growth for Macroplastique in fourth-quarter 2010

Leading stem cell scientists to discuss on stem cell clinical trials for ALS and heart attack patients

Diving "feet first" can prevent spinal cord injuries

Canadian Diabetes Association urges people with diabetes to quit smoking to improve overall health

UCI scientists create eight-layer, early-stage retina from human embryonic stem cells

Researchers use new imaging technique to view microvessels in the brains of living mice

Impulse Monitoring signs agreement to provide Tufts Medical Center IONM services

Researchers discover gene mutations in autistic, mentally impaired patients

UCSF scientists discover new stem cell in developing human brain

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

Medtronic fiscal year 2010 revenue up 8% to $15.817 billion

Biogen Idec, Abbott commence enrollment in Phase III comparative study of daclizumab to AVONEX for RRMS

Stem cell research could lead to new treatment strategies for motor neuron disease

New electronic device regulates nerve cell activity

IGF1 drug improves nerve cell communication in PMS mouse model

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News